title: [The value of clodronate (C12MDP) in the treatment of primary postmenopausal hyperparathyroidism].
authors.forename: H
authors.initials: H
authors.lastname: Rico
authors.forename: J A
authors.initials: JA
authors.lastname: Cabranes
authors.forename: E R
authors.initials: ER
authors.lastname: Hernández
authors.forename: J
authors.initials: J
authors.lastname: del Olmo
authors.forename: G
authors.initials: G
authors.lastname: Escudero
mesh_terms: D002118:Calcium / Q000097:blood; D005260:Female; D006961:Hyperparathyroidism / Q000188:drug therapy* / Q000209:etiology; D008593:Menopause; D010024:Osteoporosis / Q000188:drug therapy; D010281:Parathyroid Hormone / Q000097:blood
chemical_list: D010281:Parathyroid Hormone; D002118:Calcium
vernacular_title: Utilidad del clodronato (C12MDP) en el tratamiento del hiperparatiroidismo primario posmenopáusico.